Posted by Michael Wonder on 14 Jul 2023
FDA approves Veklury (remdesivir) for COVID-19 treatment in patients with severe renal impairment, including those on dialysis
14 July 2023 - Veklury is now the first approved anti-viral treatment for patients across all stages of renal disease.
Gilead Sciences today announced that the US FDA approved a supplemental new drug application for the use of Veklury (remdesivir) in COVID-19 patients with severe renal impairment, including those on dialysis.
